Skip to main navigation Skip to search Skip to main content

C19: A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel-Group Study Of Apl-9 In Mild To Moderate Ards Due To Covid-19

Project: Research

Project Details

StatusFinished
Effective start/end date06/1/20 → 12/31/22

Funding

  • Apellis Pharmaceuticals: $25,597.50